Method and system for disease diagnosis via simultaneous detection of antibodies bound to synthetic and cellular substrates

Details for Australian Patent Application No. 2011217190 (hide)

Owner Medipan GmbH

Inventors Knutter, Ilka; Radau, Boris; Roggenbuck, Dirk

Agent Cullens

Pub. Number AU-A-2011217190

PCT Pub. Number WO2011/101487

Priority 10075079.3 22.02.10 EP

Filing date 22 February 2011

Wipo publication date 25 August 2011

International Classifications

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

G01N 33/564 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for pre-existing immune complex or autoimmune disease

Event Publications

17 May 2012 PCT application entered the National Phase

  PCT publication WO2011/101487 Priority application(s): WO2011/101487

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011217199-Deuterated pyrrolopyrimidine compounds as inhibitors of CDK4/6

2011217181-Use of transforming growth factor - beta 1 (TGF-beta1) inhibitor peptides for the treatment of corneal fibrosis and/or haze